Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Sell
17
NAOV Quote, Financials, Valuation and Earnings
Last price:
$0.92
Seasonality move
:
0.38%
Day range:
$0.88 - $0.92
52-week range:
$0.67 - $16.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
0.07x
Volume:
306K
Avg. volume:
6.9M
1-year change:
-88.81%
Market cap:
$2.3M
Revenue:
$2.6M
EPS (TTM):
-$15.18
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, NanoVibronix has 81333.23% upside to fair value with a price target of -- per share.
NAOV vs. S&P 500
-
Over the past 5 trading days, NanoVibronix has underperformed the S&P 500 by -11.92% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
NanoVibronix does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NanoVibronix has grown year-over-year revenues for 1 quarter straight. In the most recent quarter NanoVibronix reported revenues of $1M.
Earnings Growth
-
NanoVibronix has grown year-over-year earnings for 0 quarters straight. In the most recent quarter NanoVibronix reported earnings per share of -$3.98.
Enterprise value:
5.5M
EV / Invested capital:
0.14x
Price / LTM sales:
0.13x
EV / EBIT:
--
EV / Revenue:
2.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.2M
Return On Assets:
-43.61%
Net Income Margin (TTM):
-210.82%
Return On Equity:
-63.03%
Return On Invested Capital:
-58.13%
Operating Margin:
-180.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $834K | $2.9M | $2.7M | $921K | $1M | |
| Gross Profit | $296K | $2M | $1.2M | $664K | $369K | |
| Operating Income | -$5M | -$2.9M | -$4.9M | -$568K | -$1.9M | |
| EBITDA | -$5M | -$3M | -$5.4M | -$547K | -$2.4M | |
| Diluted EPS | -$40.70 | -$18.44 | -$15.18 | -$2.38 | -$3.98 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.4M | $7.4M | $4.6M | $5.9M | $3.9M | |
| Total Assets | $8.6M | $7.7M | $4.8M | $6.2M | $44.1M | |
| Current Liabilities | $876K | $2M | $2.3M | $2.4M | $8.2M | |
| Total Liabilities | $4.3M | $2.4M | $2.6M | $2.7M | $8.4M | |
| Total Equity | $4.3M | $5.3M | $2.2M | $3.5M | $35.7M | |
| Total Debt | -- | -- | -- | -- | $3.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.5M | -$3M | -$3.3M | -$579K | -$1.3M | |
| Cash From Investing | -$4K | -$1K | $141K | -$1K | $143K | |
| Cash From Financing | $2.1M | $4.2M | $1.1M | -- | $1.1M | |
| Free Cash Flow | -$6.5M | -$3M | -$3.3M | -$580K | -$1.3M | |
NAOV
Sector
Market Cap
$2.3M
$32.8M
Price % of 52-Week High
5.57%
46.28%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-88.81%
-35.38%
Beta (5-Year)
1.754
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.00
200-day SMA
Sell
Level
$5.10
Bollinger Bands (100)
Sell
Level
1.72 - 5.48
Chaikin Money Flow
Sell
Level
-143.3M
20-day SMA
Sell
Level
$1.01
Relative Strength Index (RSI14)
Sell
Level
34.67
ADX Line
Sell
Level
14.36
Williams %R
Buy
Level
-88.7074
50-day SMA
Sell
Level
$3.06
MACD (12, 26)
Sell
Level
-0.47
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
293.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-28.7592)
Sell
CA Score
(Annual)
Level (-3.617)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (8.6969)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
Stock Forecast FAQ
In the current month, NAOV has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NAOV average analyst price target in the past 3 months is --.
-
Where Will NanoVibronix Stock Be In 1 Year?
According to analysts, the consensus estimate is that NanoVibronix share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About NanoVibronix?
Analysts are divided on their view about NanoVibronix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NanoVibronix is a Sell and believe this share price will drop from its current level to --.
-
What Is NanoVibronix's Price Target?
The price target for NanoVibronix over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NAOV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NanoVibronix is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NAOV?
You can purchase shares of NanoVibronix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NanoVibronix shares.
-
What Is The NanoVibronix Share Price Today?
NanoVibronix was last trading at $0.92 per share. This represents the most recent stock quote for NanoVibronix. Yesterday, NanoVibronix closed at $0.91 per share.
-
How To Buy NanoVibronix Stock Online?
In order to purchase NanoVibronix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will RocketLab Stock Be In 5 Years?
Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…
Is MO dividend Worth It?
Altria Group (NYSE: MO) is paying investors $1.02 a share…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 6.74% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 3.12% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.55% over the past day.
